WHAT IS SEMAGLUTIDE?
Meet Semaglutide, a medication whose revolutionary action has made it the go-to choice for treating type 2 diabetes and long term weight management. Popularly known as Ozempic, this FDA approved incretin mimetic helps to lower both blood sugar levels and A1C readings in those affected by obesity or other metabolic conditions. With its introduction into play, healthcare providers now have an innovative solution at their disposal – one that could ultimately revolutionize how we perceive such chronic conditions!
HOW DOES SEMAGLUTIDE / OZEMPIC / WEGOVY WORK?
Semaglutide combines the effectiveness of a GLP-1 receptor agonist with an appetite suppressant to create an effective dual approach for weight management. By mimicking the action of human incretin glucagon-like peptide-1, this medication increases insulin production in the body and balances it out, resulting in suppressed appetites that can lead to caloric reductions and ultimately substantial weight loss simply by eating less.
WHIO IS A GOOD CANDIDATE FOR SEMAGLUTIDE / OZEMPIC / WEGOVY?
Managing weight is no easy task, but with the introduction of medications like Semaglutide (Ozempic / Wegovy) it has become a more achievable goal. It has been approved by the FDA for adults aged 12+ as well as those with BMIs 27 or higher (and accompanied issues such as diabetes). Furthermore, Wegovy’s once-weekly injection makes reducing caloric intake and exercising easier to manage. With careful adherence to recommended practices, results can be seen in just weeks!